Search

Your search keyword '"Kim, N."' showing total 247 results

Search Constraints

Start Over You searched for: Author "Kim, N." Remove constraint Author: "Kim, N." Publication Type Conference Materials Remove constraint Publication Type: Conference Materials
247 results on '"Kim, N."'

Search Results

16. Abstract CT190: Latin American patient subgroup analysis of the phase 3 TITAN study: Apalutamide plus ADT in metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

17. Abstract 359: Molecular signatures associated with long-term response to apalutamide (APA) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in TITAN

19. Abstract A18: Plasma circulating tumor DNA is scarce and confounded by clonal hematopoiesis in metastatic renal cell carcinoma

20. Abstract A24: Identifying the genomic and clinical features of AKT1/PIK3CA mutant metastatic prostate cancer using circulating tumor DNA

30. Highly-Doped Through-Contact Silicon Epi Design at 3 nm node

34. Vertically Stacked Gate-All-Around Si Nanowire CMOS Transistors with Reduced Vertical Nanowires Separation, New Work Function Metal Gate Solutions, and DC/AC Performance Optimization

35. Si/SiGe superlattice I/O finFETs in a vertically-stacked Gate-All-Around horizontal Nanowire Technology

36. Highly conductive metal gate fill integration solution for extremely scaled RMG stack for 5 nm & beyond

38. Vertically stacked gate-all-around Si nanowire transistors: Key Process Optimizations and Ring Oscillator Demonstration

39. Multi-channel InP-based Coherent PICs with Hybrid Integrated SiGe Electronics Operating up to 100 GBd, 32QAM

41. Universality of the tunable-barrier electron pump at the part-per-million level

42. Ultra-low NMOS contact resistivity using a novel plasma-based DSS implant and laser anneal for post 7 nm nodes

43. PMOS contact resistance solution compatible to CMOS integration for 7 nm node and beyond

46. The Influence of Different Cucumariosides on Immunogenicity of OmpF Porin from Yersinia Pseudotuberulosis as a Model Protein Antigen of Tubular Immunostimulating Complex.

47. Abstract CT302: Pharmacokinetics (PK) and safety of ARN-509 with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Catalog

Books, media, physical & digital resources